SS
VIR icon

Steve Schonfeld’s Vir Biotechnology VIR Stock Holding History

Steve Schonfeld’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$753K Sell
73,914
-296,214
-80% -$2.82M ﹤0.01% 1647
2026
Q1 		$3.32M Buy
+370,128
New +$2.95M 0.02% 621
2025
Q2 		– Sell
-138,127
Closed -$895K – 2573
2025
Q1 		$895K Buy
+138,127
New +$1.23M 0.01% 1335
2024
Q4 		– Sell
-52,276
Closed -$392K – 2417
2024
Q3 		$392K Sell
52,276
-223,485
-81% -$1.94M ﹤0.01% 1537
2024
Q2 		$2.45M Buy
275,761
+253,395
+1,133% +$2.43M 0.02% 820
2024
Q1 		$227K Buy
+22,366
New +$228K ﹤0.01% 1745
2023
Q4 		– Sell
-162,128
Closed -$1.52M – 2249
2023
Q3 		$1.52M Buy
162,128
+138,387
+583% +$1.97M 0.01% 897
2023
Q2 		$582K Buy
+23,741
New +$596K 0.01% 1164
2023
Q1 		– Sell
-24,600
Closed -$623K – 2686
2022
Q4 		$623K Sell
24,600
-47,495
-66% -$1.16M 0.01% 1408
2022
Q3 		$1.39M Buy
72,095
+9,795
+16% +$249K 0.01% 1067
2022
Q2 		$1.59M Buy
62,300
+50,313
+420% +$1.17M 0.02% 821
2022
Q1 		$309K Sell
11,987
-9,313
-44% -$276K ﹤0.01% 1680
2021
Q4 		$892K Buy
+21,300
New +$834K 0.01% 991

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Steve Schonfeld's VIR Position: Q2 2026 in Review

Steve Schonfeld reduced its Vir Biotechnology (VIR) stake by 80% in Q2 2026, selling an estimated $2.82M and leaving 73,914 shares worth $753K. The position accounts for ﹤0.01% of the portfolio, ranked #1647.

Steve Schonfeld first reported a position in VIR in Q4 2021 and has held it in 13 quarters since. The position peaked at $3.32M in Q1 2026. 236 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • Steve Schonfeld held 73,914 shares of Vir Biotechnology worth $753K as of Q2 2026.
  • Steve Schonfeld sold 296,214 Vir Biotechnology shares in Q2 2026, an estimated $2.82M.
  • Vir Biotechnology made up ﹤0.01% of Steve Schonfeld's portfolio in Q2 2026, its #1647 holding.
  • Steve Schonfeld first reported a position in Vir Biotechnology in Q4 2021 and has held it in 13 quarters since.
  • Steve Schonfeld's Vir Biotechnology position peaked at $3.32M in Q1 2026.
  • 236 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.